408 563

Cited 53 times in

Analysis of neointima development in flow diverters using optical coherence tomography imaging.

DC Field Value Language
dc.contributor.author정준호-
dc.date.accessioned2018-11-16T16:55:15Z-
dc.date.available2018-11-16T16:55:15Z-
dc.date.issued2018-
dc.identifier.issn1759-8478-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/165475-
dc.description.abstractBACKGROUND: Flow diverters are used for the treatment of intracranial aneurysms. Surface modification may decrease the thrombogenicity of flow diverters but the details are unknown. Optical coherence tomography (OCT) is an intravascular imaging test with high resolution which identifies neointimal growth over stents. We compared the development of neointima in a flow diverter and stents with and without surface modification in a swine model. METHODS: In this study we implanted four devices (two in each carotid artery) in four pigs. The devices used were the Pipeline Flex embolization device (PED Flex, n=6), PED with Shield technology (PED Shield, n=6), and Solitaire AB (n=4). Serial carotid angiographic and OCT images were obtained on days 0, 7, 14, and 21. The data analyzed included: neointimal area (lumen area - stent area), neointimal ratio ([lumen area - stent area]/stent area), and the neointimal thickness ratio (minimum neointimal thickness/maximum neointimal thickness). RESULTS: There was no significant difference in where neointima formation was initiated in relation to the implanted device (distal vs middle vs proximal). The PED Shield had a trend towards earlier endothelial formation at day 7. By day 21 the neointimal ratio was significantly higher for the PED Flex and PED Shield devices than for Solitaire (p<0.05 and p<0.01, respectively). The neointimal thickness ratio was significantly higher with PED Shield than with PED Flex and Solitaire (p<0.05 and p<0.01, respectively). CONCLUSIONS: OCT enabled us to follow and compare in vivo the development of neointima over implants. PED Shield showed a similar neointimal volume to PED Flex and more concentric neointima.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageEnglish-
dc.publisherBMJ Publishing Group-
dc.relation.isPartOfJOURNAL OF NEUROINTERVENTIONAL SURGERY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnimals-
dc.subject.MESHCarotid Arteries/diagnostic imaging*-
dc.subject.MESHCarotid Arteries/surgery-
dc.subject.MESHDrug-Eluting Stents-
dc.subject.MESHEmbolization, Therapeutic/adverse effects-
dc.subject.MESHEmbolization, Therapeutic/instrumentation*-
dc.subject.MESHIntracranial Aneurysm/diagnostic imaging-
dc.subject.MESHIntracranial Aneurysm/therapy-
dc.subject.MESHNeointima/diagnostic imaging*-
dc.subject.MESHNeointima/etiology-
dc.subject.MESHStents*-
dc.subject.MESHSwine-
dc.subject.MESHTomography, Optical Coherence/methods*-
dc.titleAnalysis of neointima development in flow diverters using optical coherence tomography imaging.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Neurosurgery (신경외과학교실)-
dc.contributor.googleauthorYoshikazu Matsuda-
dc.contributor.googleauthorJoonho Chung-
dc.contributor.googleauthorDemetrius K Lopes-
dc.identifier.doi10.1136/neurintsurg-2016-012969-
dc.contributor.localIdA03731-
dc.relation.journalcodeJ02880-
dc.identifier.eissn1759-8486-
dc.identifier.pmid28592484-
dc.subject.keywordDevice-
dc.subject.keywordFlow Diverter-
dc.subject.keywordIntervention-
dc.subject.keywordStent-
dc.subject.keywordVessel Wall-
dc.contributor.alternativeNameChung, Joon Ho-
dc.contributor.affiliatedAuthor정준호-
dc.citation.volume10-
dc.citation.number2-
dc.citation.startPage162-
dc.citation.endPage167-
dc.identifier.bibliographicCitationJOURNAL OF NEUROINTERVENTIONAL SURGERY, Vol.10(2) : 162-167, 2018-
dc.identifier.rimsid58939-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurosurgery (신경외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.